Pan-inhibition of super-enhancer-driven oncogenic transcription by next-generation synthetic ecteinascidins yields potent anti-cancer activity.
Cigrang M, Obid J, Nogaret M, Seno L, Ye T, Davidson G, Catez P, Berico P, Capelli C, Marechal C, Zachayus A, Elly C, Guillen Navarro MJ, Martinez Diez M, Santamaria Nunez G, Li TK, Compe E, Avilés P, Davidson I, Egly JM, Cuevas C, Coin F.
Cigrang M, et al. Among authors: li tk.
Nat Commun. 2025 Jan 8;16(1):512. doi: 10.1038/s41467-024-55667-z.
Nat Commun. 2025.
PMID: 39779693